MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue-Reference-Cited by-同舟云学术

MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue

Published:2014-03 Issue:2 Volume:16 Page:190-197
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Sapino Anna,Roepman Paul,Linn Sabine C.,Snel Mireille H.J.,Delahaye Leonie J.M.J.,van den Akker Jeroen,Glas Annuska M.,Simon Iris M.,Barth Neil,de Snoo Femke A.,van ’t Veer Laura J.,Molinaro Luca,Berns Els M.J.J.,Wesseling Jelle,Riley Lee B.,Anderson David,Nguyen Bichlien,Cox Charles E.

Funder

Top Institute Pharma

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference32 articles.

1. Gene expression profiling predicts clinical outcome of breast cancer;van ’t Veer;Nature,2002

2. A gene-expression signature as a predictor of survival in breast cancer;van de Vijver;N Engl J Med,2002

3. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer;Buyse;J Natl Cancer Inst,2006

4. Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort;Wittner;Clin Cancer Res,2008

5. The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study;Mook;Breast Cancer Res Treat,2009

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review and feasibility study on pre-analytical factors and genomic analyses on archival formalin-fixed paraffin-embedded breast cancer tissue;Scientific Reports;2024-08-06

2. The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy;International Journal of Molecular Sciences;2024-05-24

3. B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer;Breast Cancer Research;2023-10-04

4. Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer;European Journal of Cancer;2022-11

5. The current staging and classification systems of breast cancer and their pitfalls: Is it possible to integrate the complexity of this neoplasm into a unified staging system?;Critical Reviews in Oncology/Hematology;2022-10